LAURUS LABS
Back to Income Statement
|
LAURUS LABS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹358 Cr | ₹158 Cr | ₹785 Cr | ₹828 Cr | ₹984 Cr |
What is the latest Consolidated Net Profit of LAURUS LABS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹358 Cr |
| Mar2024 | ₹158 Cr |
| Mar2023 | ₹785 Cr |
| Mar2022 | ₹828 Cr |
| Mar2021 | ₹984 Cr |
How is Consolidated Net Profit of LAURUS LABS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹358 Cr | 127.25 | |
| Mar2024 | ₹158 Cr | -79.90 | |
| Mar2023 | ₹785 Cr | -5.20 | |
| Mar2022 | ₹828 Cr | -15.87 | |
| Mar2021 | ₹984 Cr | - | |
Compare Consolidated Net Profit of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹59,175.7 Cr | -0.2% | 15.1% | 80.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -1.9% | -7.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,939.0 Cr | 1.8% | 3.3% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,109.0 Cr | -0.5% | -4% | 29.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,578.0 Cr | 0.2% | -4.9% | 6.6% | Stock Analytics | |
| CIPLA | ₹99,761.1 Cr | 0.5% | -3.8% | -17% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | -0.2% |
15.1% |
80.6% |
| SENSEX | 0.5% |
3.2% |
2.3% |
You may also like the below Video Courses